Tech Company Financing Transactions

Elligo Health Research Funding Round

Elligo Health Research, based in Austin, scored $135 million from Ally Bridge Group, Morgan Stanley Expansion Capital and Cerner.

Transaction Overview

Company Name
Elligo Health Research
Announced On
9/27/2021
Transaction Type
Venture Equity
Amount
$135,000,000
Round
Series E
Investors

Ally Bridge Group (Lead Investor)

Morgan Stanley Expansion Capital (Lead Investor) (Melissa Daniels)

Cerner

Hatteras Venture Partners (John Crumpler)

Noro-Moseley Partners (Allen Moseley)

Norwest Venture Partners

Piper Sandler

Shumway Capital

Syneos Health

Proceeds Purpose
The company intends to use the funds to acquire ClinEdge and invest further in the technology & data platform.

Company Information

Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
11612 Bee Cave Rd. Bldg. 1 150
Austin, TX 78738
USA
Phone
(512) 580-4633
Website
www.elligohealthresearch.com
Email Address
[email protected]
Overview
We bring treatment options to patients from physicians they trust so sponsors can conduct more efficient, cost-effective trials and take products to market faster.
Profile
Elligo Health Research LinkedIn Company Profile
Social Media
Elligo Health Research Company Twitter Account
Company News
Elligo Health Research News
Facebook
Elligo Health Research on Facebook
YouTube
Elligo Health Research on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
John Potthoff
  John Potthoff LinkedIn Profile  John Potthoff Twitter Account  John Potthoff News  John Potthoff on Facebook
Chief Financial Officer
Karen Flaherty
  Karen Flaherty LinkedIn Profile  Karen Flaherty Twitter Account  Karen Flaherty News  Karen Flaherty on Facebook
Chief Information Officer
Jacylyn Dougherty
  Jacylyn Dougherty LinkedIn Profile  Jacylyn Dougherty Twitter Account  Jacylyn Dougherty News  Jacylyn Dougherty on Facebook
Chief Medical Officer
Faith Holmes
  Faith Holmes LinkedIn Profile  Faith Holmes Twitter Account  Faith Holmes News  Faith Holmes on Facebook
Chief Operating Officer
Miranda Porter
  Miranda Porter LinkedIn Profile  Miranda Porter Twitter Account  Miranda Porter News  Miranda Porter on Facebook
Chief Scientific Officer
Rebecca Kush
  Rebecca Kush LinkedIn Profile  Rebecca Kush Twitter Account  Rebecca Kush News  Rebecca Kush on Facebook
Co-Founder
Chad Moore
  Chad Moore LinkedIn Profile  Chad Moore Twitter Account  Chad Moore News  Chad Moore on Facebook
Vice President
Katie Eyestone
  Katie Eyestone LinkedIn Profile  Katie Eyestone Twitter Account  Katie Eyestone News  Katie Eyestone on Facebook
Vice President
Michael Ibara
  Michael Ibara LinkedIn Profile  Michael Ibara Twitter Account  Michael Ibara News  Michael Ibara on Facebook
Vice President
Vanessa Watson
  Vanessa Watson LinkedIn Profile  Vanessa Watson Twitter Account  Vanessa Watson News  Vanessa Watson on Facebook
VP - Administration
Eli Alford
  Eli Alford LinkedIn Profile  Eli Alford Twitter Account  Eli Alford News  Eli Alford on Facebook
VP - Bus. Development
Brandon Cormier
  Brandon Cormier LinkedIn Profile  Brandon Cormier Twitter Account  Brandon Cormier News  Brandon Cormier on Facebook
VP - Bus. Development
Keith Fern
  Keith Fern LinkedIn Profile  Keith Fern Twitter Account  Keith Fern News  Keith Fern on Facebook
VP - Bus. Development
Michael Gibertini
  Michael Gibertini LinkedIn Profile  Michael Gibertini Twitter Account  Michael Gibertini News  Michael Gibertini on Facebook

 

 

Browse more venture capital transactions:

Prev: 9/27/2021: GenEdit venture capital transaction
Next: 9/27/2021: RaySecur venture capital transaction

 

Share this article

 

About Our VC Transactions Data

We do our best to report on funding rounds that are announced publicly. VC investment data records on this site are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.